2013-03-05 14:44:38 UTC

<em>H. Pylori</em> Infection Influences Peptic Ulcer Bleeding in Low-Dose Aspirin Users

March 7, 2013

Publishing in Gastroenterology, Francis Chan and colleagues report that the long-term incidence of recurrent ulcer bleeding with low-dose aspirin use is low after Helicobacter pylori (H. pylori) infection is eradicated.

Current guidelines recommend testing for Helicobacter pylori (H. pylori) infection among users of low-dose aspirin who are at high risk for developing ulcers. However, it is not clear whether this strategy affects long-term risk of ulcer bleeding. Francis Chan and colleagues assessed the utility of testing low-dose aspirin users with a high risk of ulcer bleeding for H. pylori infection. Publishing in Gastroenterology, the researchers report that the long-term incidence of recurrent ulcer bleeding with low-dose aspirin use is low after H. pylori infection is eradicated. Low-dose aspirin users without current or past H. pylori infections who develop ulcer bleeding have a high risk of recurrent bleeding. Tests for H. pylori infection can be used to assign high-risk low-dose aspirin users to groups that require different gastroprotective strategies. 

Gastroenterology 2013: 144(3): 528-535

More on Helicobacter pylori Infection

Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial

Oct. 22, 2017

This randomized clinical trial with 13 years of follow-up evaluation, designed to provide evidence on the effect of H pylori population screening, showed no significant long-term effect when compared with usual care in this low-prevalence area.

Submucosal Tumor of the Stomach With Drastic, Short-Term Changes in Morphology

Aug. 10, 2017

What caused the lesion in a man diagnosed with a submucosal tumor in the upper gastric corpus, to change to a reddish, semipedunculated tumor with blood oozing on the surface?

Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells

July 1, 2017

Cell surface adhesion molecule CD44 has been identified as a gastric cancer stem cell marker.